Home > News Release List

News Release List


2017:


2016:


2015:

Release
Janurary 16, 2015
Conclusion of a Patent Licensing Agreement with Cosmo Oil
Release
Janurary 14, 2015
Acquisition of a Patent for Prophylactic/Ameliorating Agent for Adult Diseases Containing 5-ALA as an Active Ingredient


2014:

Release
August 21, 2014
Presentation of Research Paper on 5-ALA by Osaka City University to PLOS ONE, a U.S. Scientific Journal - Findings of ALA-PDT in killing MRSA, one of the major bacterial species causing in-hospital infections -
Release
July 30, 2014
Conclusion of Agreement on Joint Research between the University of Oxford in the United Kingdom and SBI Pharmaceuticals
Release
May 29, 2014
Proposal on Development of Green Light Source is Selected for NEDO's "FY2013 Innovation Commercialization Venture Support Project"
Release
April 22, 2014
SBI Pharmaceuticals Officers to Serve as Visiting Professors at Fudan University in China
Release
April 1, 2014
Release of Medical Light Source "Bicolor LED Light Source Aladuck LS-DLED"
Release
March 28, 2014
Notice Regarding Start of Clinical Studies on Type 2 Diabetes by Using 5-ALA at the Bahrain Defense Force Royal Medical Service Hospital
Release
March 17, 2014
ReproCELL and SBI Pharmaceuticals Agree on a Joint Research Regarding ES/iPS Cell Technology Using 5-ALA
Release
February 3, 2014
Announcement of Communication to Grant a Patent in Europe for Therapeutic Agent for Male Sterility through Administration of 5-Aminolevulinic Acid
Release
January 21, 2014
Announcement of Decision to Grant a Patent in Japan for Method of Detecting Bladder Cancer through Oral Administration of 5-Aminolevulinic Acid
Release
January 16, 2014
Announcement of the First Successful Surgical Removal of Bladder Cancer in the Middle East Using 5-Aminolevulinic Acid as an Intraoperative Diagnostic Drug at a Medical Center of Arabian Gulf University in Bahrain

2013:

Release
December 18, 2013
Presentation of Research Paper on 5-ALA by Kochi University to PLoS ONE, a U.S. Scientific Journal
Release
December 3, 2013
Findings of Mechanism of 5-aminolevulinic Acid (5-ALA) and Iron in Synergistically Inhibiting Growth of Plasmodium Falciparum Malaria Parasites
Release
September 26, 2013
New Launch of "ALAGLIO Internal Medicine 1.5g," an Orally-administered in vivo Diagnostic Agent for Malignant Glioma
Release
September 20, 2013
SBI Pharmaceuticals Obtains a Business License for Selling and Renting Highly Controlled Medical Devices
Release
August 30, 2013
SBI Pharmaceuticals Submits a Phase-2 Clinical Trial CTA to MHRA for a Drug to Treat Cancer Chemotherapy-induced Anemia
Release
August 27, 2013
Announcement-the new drug "ALAGLIO Internal Medicine 1.5g", an Orally-administered in vivo Diagnostic for Malignant Glioma, is Listed on the NHI Drug Price List
Release
August 26, 2013
Notice Regarding Conclusion of Basic Agreement with King Hamad University Hospital in Bahrain on Clinical Study of 5-aminolevulinic acid
Release
June 25, 2013
Presentation of Research Paper on 5-ALA by Hiroshima University to Nutrition, a U.S. Scientific Journal   - Results of Clinical Research on Relationship between 5-ALA and Blood Glucose Levels Announced -
Release
March 25, 2013
SBI Pharmaceuticals Obtains Manufacture and Marketing Approval for Orally-administered in vivo Diagnostic Agent "ALAGLIO" for Malignant Glioma
Release
March 21, 2013
Agreement to Collaborate Reached with the Royal College of Surgeons in Ireland - Medical University of Bahrain for Starting Clinical Studies
Release
March 21, 2013
Memorandum of Understanding between Mumtalakat, the Sovereign Wealth Fund of Bahrain, and SBI Pharmaceuticals Co., Ltd. to Cooperate in the 5-ALA Business in Bahrain Focusing on the Pharmaceuticals Industry
Release
March 21, 2013
Notice on the Establishment of Joint Venture Company with Dawani Group Holding, a Major Corporate Group in Bahrain
Release
March 21, 2013
Basic Agreement Reached with the Bahrain Development Bank for Promoting 5-ALA Business in Bahrain
Release
March 21, 2013
Joint Clinical Research on Diabetes with Arabian Gulf University in Bahrain
Release
February 7, 2013
Notice on the Establishment of Joint Venture Company with Dawani Group Holding, Bahrain's Major Corporate Group for Sales of 5-ALA Products
Release
January 21, 2013
SBI Pharmaceuticals Announces Conclusion of Basic Agreement to Start Clinical Research on Diabetes with Arabian Gulf University in Bahrain
Release
January 16, 2013
Notice on the Press Release Published by the Bahrain Economic Development Board
Release
January 7, 2013
SBI Pharmaceuticals Submits a Phase-1 Clinical Trial IND to U.S. FDA for a Drug to Treat Cancer Chemotherapy-induced Anemia

2012:

Release
October 11, 2012
SBI Pharmaceuticals Submits a Phase-1 Clinical Trial CTA to MHRA for a Drug to Treat Cancer Chemotherapy-induced Anemia
Release
October 11, 2012
SBI Pharmaceuticals Obtains the Product License of Healthy Supplement from the Dubai Authority
Release
October 10, 2012
SBI Pharmaceuticals Opens a Representative Office in Bahrain
Release
September 20, 2012
Notice on the Appointment of a New Executive Officer
Release
August 1, 2012
Notice on the Appointment of a New Director
Release
July 6, 2012
Notice on application for marketing approval of in vivo diagnostic agent for malignant glioma in Japan
Release
July 3, 2012
Notice on Posting a News on Bahraini Industry and Commerce Ministry's Website
Release
June 26, 2012
Notice on Publication by Univ. of Hawaii of Paper on 5-ALA in Electronic Edition of U.S. Science Journal Clinical and Translational Science
Release
April 24, 2012
SBI Pharmaceuticals Announces Obtainment of Marketing Authorization of Products Containing 5-ALA from The Kingdom of Bahrain Ministry of Health
Release
April 13, 2012
Notice on Agreement with Bahrain Government for the Promotion of the 5-ALA Business
Release
February 29, 2012
Notice on SBI ALApromo's Obtainment of First-class Marketing Authorization and Restructuring of ALA-related Business

2011:

Release
October 28, 2011
ALA Study Results Presented at the 49th Annual Meeting of Japan Society of Clinical Oncology (2)
Release
October 28, 2011
ALA Study Results Presented at the 49th Annual Meeting of Japan Society of Clinical Oncology (1)
Release
October 21, 2011
ALA Study Results Presented at 39th Annual Meeting of Japanese Association for Acute Medicine
Release
October 5, 2011
The study Results of ALA Presented Japanese Cancer Association, 70th Annual Meeting (3)
Release
October 5, 2011
The study Results of ALA Presented Japanese Cancer Association, 70th Annual Meeting (2)
Release
October 5, 2011
The study Results of ALA Presented Japanese Cancer Association, 70th Annual Meeting (1)
Release
October 3, 2011
ALA Study Results Presented at Japanese Society of Parasitology, 71st Meeting.
Release
May 17, 2011
Notice of Announcement of Research Results at the 65th Annual Meeting of the Japanese Society of Nutrition and Food Science
Release
March 18, 2011
Announcement of publication of ALA research in International Immunopharmacology

2010:

Release
November 30, 2010
Announcement of orphan drug designation granted to orally active in vivo diagnostic agent for malignant glioma
Release
May 27, 2010
Announcement of initiation of Phase III clinical study of orally active in vivo diagnostic agent for malignant glioma

2009:

News
July 13, 2009
Development of products containing "5-ALA (5-Aminolevulinic Acid)" of ALApromo Co., Ltd. was introduced in the feature article of biotechnology ventures in Japan on page 10 of Nikkei Industrial News.
Updated news
January 26, 2009
Information of beauty cream "HANAMITSU" was added to the "Products" page.

2008:

News
October 22, 2008
Musashi Institute of Technology (currently named Tokyo City University) "the 14th My-Tech academic-industrial technology collaboration meeting"-New development for improvement of public health, medicine, and environments for humans with the use of a new functional amino acid (5-ALA: 5-Aminolevulinic Acid)-
Page Top